We here report on the establishment of (i) a panel of assays that
allow to identify inhibitors of ZIKV replication as well as (ii) a robust animal model of ZIKV
infection with brain involvement. The viral polymerase inhibitor 7-deaza-2’-C-methyladenosine
(7DMA) was identified as an inhibitor of in vitro ZIKV replication and was shown to
reduce viremia and to delay the time to disease progression in virus-infected mice.